Opdivo, Twitter, 3/23/2019 6:59:05 AM, 191362


FAQ | Problem?

Opdivo_2019-03-22_14-49-02.xlsx
Opdivo_2019-03-22_14-49-02.xlsx
From:
NodeXLExcelAutomator
Uploaded on:
March 23, 2019
Short Description:
Opdivo via NodeXL http://bit.ly/2U5AvBo
@bmsnews
@andybiotech
@drchoueiri
@fundyaraposible
@matthewherper
@bpiperdi
@oncomedven
@amerseburger
@alvie_barr
@quimioterapiao

Top hashtags:
#opdivo
#nivolumab
#sanfelipe
#yaracuy
#rituximab
#avastin
#capecitabina
#zoladex

Description:
Description
The graph represents a network of 1,784 Twitter users whose tweets in the requested range contained "Opdivo", or who were replied to or mentioned in those tweets. The network was obtained from the NodeXL Graph Server on Friday, 22 March 2019 at 21:49 UTC.

The requested start date was Thursday, 21 March 2019 at 00:01 UTC and the maximum number of tweets (going backward in time) was 5,000.

The tweets in the network were tweeted over the 78-day, 23-hour, 35-minute period from Tuesday, 01 January 2019 at 00:17 UTC to Wednesday, 20 March 2019 at 23:53 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 1784
Unique Edges : 1894
Edges With Duplicates : 1079
Total Edges : 2973
Number of Edge Types : 3
Mentions : 1947
Tweet : 734
Replies to : 292
Self-Loops : 734
Reciprocated Vertex Pair Ratio : 0.0170068027210884
Reciprocated Edge Ratio : 0.0334448160535117
Connected Components : 371
Single-Vertex Connected Components : 243
Maximum Vertices in a Connected Component : 492
Maximum Edges in a Connected Component : 1025
Maximum Geodesic Distance (Diameter) : 13
Average Geodesic Distance : 4.007103
Graph Density : 0.000563996287810387
Modularity : 0.616497
NodeXL Version : 1.0.1.409

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[35] https://www.statnews.com/2019/01/24/in-disappointment-bristol-pulls-fda-application-for-opdivo-combination-in-lung-cancer/
[32] https://www.ono.co.jp/eng/news/pdf/sm_cn190109.pdf
[22] https://scr.zacks.com/News/Press-Releases/Press-Release-Details/2019/DYAI-SEC-Form-10-Deemed-Effective/default.aspx
[18] https://endpts.com/after-some-kickback-from-the-fda-bristol-myers-yanks-its-opdivo-yervoy-bla-for-high-tmb-approach-to-lung-cancer/
[18] https://news.bms.com/press-release/corporatefinancial-news/european-commission-approves-opdivo-nivolumab-plus-low-dose-ye
[17] http://brazilsfecompany.blogspot.com.br/2018/04/2018-Top-20-Medicamentos-Mais-Vendidos-no-Mundo.html
[17] https://twitter.com/BrazilSFE
[11] http://medsminders.com/medsminders-app/
[11] https://www.diariomedico.com/salud/via-libre-de-la-ce-para-opdivo-mas-yervoy-en-carcinoma-de-celulas-renales.html
[9] http://braintumorstorageoptions.ca

Top URLs in Tweet in G1:
[17] http://brazilsfecompany.blogspot.com.br/2018/04/2018-Top-20-Medicamentos-Mais-Vendidos-no-Mundo.html
[17] https://twitter.com/BrazilSFE
[11] http://medsminders.com/medsminders-app/
[10] https://www.diariomedico.com/salud/via-libre-de-la-ce-para-opdivo-mas-yervoy-en-carcinoma-de-celulas-renales.html
[6] https://news.bms.com/press-release/corporatefinancial-news/european-commission-approves-opdivo-nivolumab-plus-low-dose-ye
[6] https://endpts.com/after-some-kickback-from-the-fda-bristol-myers-yanks-its-opdivo-yervoy-bla-for-high-tmb-approach-to-lung-cancer/
[5] http://min-voice.com/opdivo-14722.html
[4] https://lungcancersymptomsx.com/a-hope-for-mesothelioma-patients-with-new-lung-cancer-drug-opdivo.html
[3] https://hedgeaccordingly.com/bristol-myers-squibb-acquires-celgene-marrying-opdivo-maker-with-revlimid-maker/
[3] https://endpts.com/bristol-myers-takes-another-hit-on-opdivo-yervoy-combo-as-chmp-turns-thumbs-down-on-frontline-kidney-cancer

Top URLs in Tweet in G2:
[27] https://www.ono.co.jp/eng/news/pdf/sm_cn190109.pdf
[15] https://www.statnews.com/2019/01/24/in-disappointment-bristol-pulls-fda-application-for-opdivo-combination-in-lung-cancer/
[10] https://endpts.com/after-some-kickback-from-the-fda-bristol-myers-yanks-its-opdivo-yervoy-bla-for-high-tmb-approach-to-lung-cancer/
[6] https://endpts.com/its-what-bristol-myers-execs-arent-saying-that-makes-one-key-analyst-wonder-about-a-potential-buyout-offer-looming-opdivo-data-and-plan-b/
[3] http://www.evaluate.com/vantage/articles/analysis/vantage-views/bristols-doomsday-scenario-could-opdivo-start-shrinking?utm_source=Twitter&utm_medium=Social&utm_campaign=evaluatepharma
[2] http://www.evaluate.com/vantage/articles/analysis/vantage-views/bristols-doomsday-scenario-could-opdivo-start-shrinking
[2] https://endpts.com/the-2018-breakdown-on-fda-new-drug-approvals-with-the-top-4-trends-in-play/
[2] http://www.evaluate.com/vantage/articles/news/trial-results/testing-times-opdivo-and-us-regulator
[2] https://myelomaresearchnews.com/2019/01/14/phase-1-trial-reolysin-opdivo-kyprolis-combo-treated-first-relapsed-multiple-myeloma-patient/
[2] https://news.bms.com/press-release/corporatefinancial-news/european-commission-approves-bristol-myers-squibbs-opdivo-nivo

Top URLs in Tweet in G5:
[9] http://braintumorstorageoptions.ca
[1] http://Braintumorstorageoptions.ca
[1] https://www.storemytumor.com/

Top URLs in Tweet in G6:
[3] https://news.bms.com/press-release/corporatefinancial-news/opdivo-nivolumab-plus-low-dose-yervoy-ipilimumab-demonstrate-0?linkId=63481717
[3] https://www.firstwordpharma.com/node/1620587
[3] https://lnkd.in/gqqck4s
[2] https://www.fiercepharma.com/marketing/merck-s-keytruda-looks-to-zoom-past-opdivo-head-and-neck-cancer-breakthrough?utm_content=84744997&utm_medium=social&utm_source=twitter&hss_channel=tw-271111167
[2] https://pharmashots.com/2019/02/bristol-myers-bms-reports-results-of-opdivo-nivolumab-yervoy-ipilimumab-in-p-ii-checkmate-650-trial-for-metastatic-castration-resistant-prostate-cancer-mcrpc/
[2] http://www.firstwordpharma.com/node/1238609
[2] https://pharmaphorum.com/news/bms-gets-new-ok-for-opdivo-yervoy-in-kidney-cancer/
[2] http://www.worldpharmanews.com/bms/4676-european-commission-approves-opdivo-nivolumab-plus-low-dose-yervoy-ipilimumab-for-first-line-treatment-of-patients-with-intermediate-and-poor-risk-advanced-renal-cell-carcinoma
[1] https://www.melanomanetwork.ca/adjuvant-therapy/
[1] https://news.bms.com/press-release/corporatefinancial-news/opdivo-nivolumab-plus-yervoy-ipilimumab-shows-response-pre-tre?linkId=63612843

Top URLs in Tweet in G7:
[5] https://news.bms.com/press-release/corporatefinancial-news/european-commission-approves-opdivo-nivolumab-plus-low-dose-ye
[1] https://immuno-oncologynews.com/2019/01/25/opdivo-yervoy-approved-europe-kidney-cancers/

Top URLs in Tweet in G9:
[1] https://twitter.com/dw_turkce/status/1068794562246787072

Top URLs in Tweet in G10:
[1] https://www.onclive.com/web-exclusives/fda-approves-nivolumab-for-small-cell-lung-cancer
[1] https://cadth.ca/pcodr
[1] https://www.onclive.com/web-exclusives/nivolumabipilimumab-combo-misses-primary-endpoint-in-phase-iii-sclc-trial
[1] https://endpts.com/after-some-kickback-from-the-fda-bristol-myers-yanks-its-opdivo-yervoy-bla-for-high-tmb-approach-to-lung-cancer/
[1] https://twitter.com/matthewherper/status/1088410208660062210
[1] https://vimeo.com/312167366/46bc03ab23?utm_content=83159272&utm_medium=social&utm_source=twitter&hss_channel=tw-77229725
[1] https://vimeo.com/312167366/46bc03ab23?utm_campaign=2019%20Oncology&utm_content=83119743&utm_medium=social&utm_source=twitter&hss_channel=tw-77229725

Top Domains
Top Domains in Tweet in Entire Graph:
[53] twitter.com
[43] co.jp
[42] statnews.com
[41] fiercepharma.com
[35] bms.com
[32] endpts.com
[29] buzzfeed.com
[23] zacks.com
[22] change.org
[22] dlvr.it

Top Domains in Tweet in G1:
[30] twitter.com
[19] com.br
[15] fiercepharma.com
[14] dlvr.it
[11] bms.com
[11] seekingalpha.com
[11] medsminders.com
[10] pharmatimes.com
[10] diariomedico.com
[9] endpts.com

Top Domains in Tweet in G2:
[27] co.jp
[18] endpts.com
[15] statnews.com
[8] twitter.com
[7] evaluate.com
[4] bms.com
[2] businesswire.com
[2] yahoo.com
[2] myelomaresearchnews.com
[1] wsw.com

Top Domains in Tweet in G5:
[10] braintumorstorageoptions.ca
[1] storemytumor.com

Top Domains in Tweet in G6:
[11] firstwordpharma.com
[5] bms.com
[5] pharmashots.com
[4] pharmaphorum.com
[3] lnkd.in
[2] fiercepharma.com
[2] yahoo.com
[2] worldpharmanews.com
[1] melanomanetwork.ca
[1] houstonchronicle.com

Top Domains in Tweet in G7:
[5] bms.com
[1] immuno-oncologynews.com

Top Domains in Tweet in G9:
[1] twitter.com

Top Domains in Tweet in G10:
[2] onclive.com
[2] vimeo.com
[1] cadth.ca
[1] endpts.com
[1] twitter.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[303] opdivo
[198] nivolumab
[135] sanfelipe
[135] yaracuy
[104] rituximab
[101] avastin
[92] capecitabina
[92] zoladex
[86] docetaxel
[77] femara



Top Hashtags in Tweet in G1:
[48] opdivo
[28] neulasta
[26] januvia
[26] lantus
[26] prevnar13
[19] lyrica
[19] harvoni
[19] tecfidera
[19] stelara
[17] janumet

Top Hashtags in Tweet in G2:
[15] immunotherapy
[2] io
[2] jpm19
[2] hpm19
[2] lungcancer
[2] opdivo
[2] keytruda
[1] oncology
[1] gu19
[1] fda

Top Hashtags in Tweet in G3:
[187] opdivo
[155] nivolumab
[100] rituximab
[98] avastin
[90] zoladex
[89] capecitabina
[84] docetaxel
[74] femara
[71] sutent
[69] letrozole

Top Hashtags in Tweet in G4:
[131] sanfelipe
[131] yaracuy
[6] opdivo
[6] nivolumab
[5] serviciopúblico
[4] rituximab
[3] capecitabina
[3] letrozole
[3] avastin
[3] femara

Top Hashtags in Tweet in G6:
[16] media
[13] gu19
[10] renalcellcarcinoma
[6] rcc
[5] opdivo
[5] prostatecancer
[5] pcsm
[5] pharma
[3] kcsm
[3] kidneycancer

Top Hashtags in Tweet in G7:
[1] rcc
[1] io
[1] nierenkrebs

Top Hashtags in Tweet in G8:
[1] ريتوييت

Top Hashtags in Tweet in G10:
[15] lcsm
[3] essclc
[3] pdl1
[3] cancer
[2] asco
[2] gi19
[1] lcms
[1] lungcancer

Top Words
Top Words in Tweet in Entire Graph:
[1023] Words in Sentiment List#1: Positive
[983] Words in Sentiment List#2: Negative
[1] Words in Sentiment List#3: Angry/Violent
[50328] Non-categorized Words
[52334] Total Words
[1942] opdivo
[639] nivolumab
[432] keytruda
[429] bmy
[402] cancer

Top Words in Tweet in G1:
[348] opdivo
[134] yervoy
[92] cancer
[90] bristol
[72] myers
[71] patients
[68] bmy
[67] nivolumab
[64] plus
[47] lung

Top Words in Tweet in G2:
[423] opdivo
[255] bmy
[154] keytruda
[119] mrk
[117] andybiotech
[109] 1
[98] 3
[97] sales
[85] pd
[75] yoy

Top Words in Tweet in G3:
[210] opdivo
[169] nivolumab
[120] oncomedven
[100] rituximab
[98] avastin
[90] zoladex
[89] capecitabina
[84] docetaxel
[80] 100mg
[74] femara

Top Words in Tweet in G4:
[142] opdivo
[142] nivolumab
[136] paciente
[133] bevacizumab
[131] lila
[131] algieri
[131] sanfelipe
[131] yaracuy
[131] oncológico
[131] requiere

Top Words in Tweet in G5:
[146] keytruda
[141] opdivo
[104] pd1
[88] dcvax
[70] lung
[69] vaccine
[67] cancers
[66] imiquimod
[65] treated
[65] approved

Top Words in Tweet in G6:
[86] opdivo
[53] bmsnews
[40] cancer
[33] bristol
[31] nivolumab
[28] myers
[28] yervoy
[26] treatment
[25] advanced
[23] patients

Top Words in Tweet in G7:
[74] nivolumab
[74] ipilimumab
[72] line
[72] treatment
[72] patients
[71] intermediate
[59] rcc
[56] poor
[55] drchoueiri
[55] official

Top Words in Tweet in G8:
[160] به
[81] و
[80] یک
[80] بیمار
[80] نیاز
[80] این
[80] داروها
[80] داره
[80] نسخه
[80] آزادش

Top Words in Tweet in G9:
[68] geri
[68] listesine
[67] barisyarkadas
[67] 1
[67] aile
[67] çalışma
[67] ve
[67] sosyal
[67] hizmetler
[67] bakanı

Top Words in Tweet in G10:
[39] opdivo
[27] cancer
[25] small
[25] cell
[25] sclc
[24] lung
[18] fda
[17] nsclc
[17] canada
[16] application

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[279] opdivo,nivolumab
[246] nivolumab,opdivo
[201] bristol,myers
[154] keytruda,opdivo
[141] lung,cancer
[139] line,treatment
[138] opdivo,100mg
[135] lila,algieri
[135] algieri,sanfelipe
[135] sanfelipe,yaracuy

Top Word Pairs in Tweet in G1:
[71] bristol,myers
[52] opdivo,nivolumab
[50] opdivo,yervoy
[42] yervoy,ipilimumab
[41] nivolumab,plus
[35] lung,cancer
[33] low,dose
[33] dose,yervoy
[30] myers,squibb
[29] plus,low

Top Word Pairs in Tweet in G2:
[108] bmy,opdivo
[76] mrk,keytruda
[71] anti,pd
[70] pd,l
[70] l,1
[69] global,anti
[69] 1,4q18
[69] 4q18,sales
[69] sales,mrk
[69] keytruda,2151m

Top Word Pairs in Tweet in G3:
[117] opdivo,nivolumab
[60] rituximab,capecitabina
[60] sutent,sunitinib
[59] zoladex,opdivo
[56] letrozole,sutent
[55] caracas,rituximab
[53] nivolumab,docetaxel
[50] avastin,bevacizumab
[49] zoldonat,zoladex
[49] sunitinib,avastin

Top Word Pairs in Tweet in G4:
[138] nivolumab,opdivo
[131] lila,algieri
[131] algieri,sanfelipe
[131] sanfelipe,yaracuy
[131] yaracuy,paciente
[131] paciente,oncológico
[131] oncológico,requiere
[131] requiere,24
[131] 24,nivolumab
[131] opdivo,100mg

Top Word Pairs in Tweet in G5:
[128] keytruda,opdivo
[66] lung,cancers
[62] fda,approved
[62] approved,keytruda
[61] high,pd1
[61] pd1,treated
[61] opdivo,lung
[60] treated,successfully
[58] label,keytruda
[56] vaccine,high

Top Word Pairs in Tweet in G6:
[28] bristol,myers
[21] nivolumab,opdivo
[14] myers,squibb
[14] first,line
[13] bmsnews,media
[12] pembrolizumab,keytruda
[12] prostate,cancer
[10] renal,cell
[10] european,commission
[9] made,bristol

Top Word Pairs in Tweet in G7:
[72] line,treatment
[71] patients,intermediate
[58] nivolumab,ipilimumab
[56] intermediate,poor
[55] official,ema_news
[55] ema_news,approves
[55] approves,nivolumab
[55] ipilimumab,1st
[55] 1st,line
[55] treatment,rcc

Top Word Pairs in Tweet in G8:
[80] یک,بیمار
[80] بیمار,نیاز
[80] نیاز,به
[80] به,این
[80] این,داروها
[80] داروها,داره
[80] داره,نسخه
[80] نسخه,آزادش
[80] آزادش,حدودا
[80] حدودا,۷۲

Top Word Pairs in Tweet in G9:
[67] 1,aile
[67] aile,çalışma
[67] çalışma,ve
[67] ve,sosyal
[67] sosyal,hizmetler
[67] hizmetler,bakanı
[67] bakanı,zehra
[67] zehra,zümrüt
[67] zümrüt,selçuk
[67] selçuk,30

Top Word Pairs in Tweet in G10:
[25] small,cell
[24] cell,lung
[24] lung,cancer
[10] bms,pulls
[10] pulls,application
[10] application,nivo
[10] nivo,ipi
[10] ipi,nsclc
[10] nsclc,see
[10] see,submission

Top Replied-To
Top Replied-To in Entire Graph:
@thenci
@matthewherper
@fundacionbadan
@jacobplieth
@biotechobserver
@sclc_lungcancer
@jq1234t
@chickpea598
@dewdiligence
@miljenkoz

Top Replied-To in G2:
@matthewherper
@biotechobserver
@jacobplieth
@jq1234t
@chickpea598
@andybiotech
@miljenkoz
@dewdiligence
@bradloncar
@supakbrian

Top Replied-To in G3:
@fundacionbadan
@oncomedven
@frmarilena
@emybc
@ca601ff0a58d454
@dionisiovii
@fundatiacruz
@serviciopublive
@fschwarzenberg

Top Replied-To in G5:
@cwilson1972
@shea_babee
@miranduhhhplz
@bmoney888
@kiarahenderson_
@herbieallstar
@geddisdee
@jkati0128
@kareninvan

Top Replied-To in G6:
@thenci
@nih

Top Replied-To in G10:
@sclc_lungcancer
@lcfamerica
@alfdoc2
@govcanhealth
@orourke_b
@jfreemandaily
@ros1cancer

Top Mentioned
Top Mentioned in Entire Graph:
@fundyaraposible
@oncomedven
@andybiotech
@mehrdad_dehqani
@barisyarkadas
@bmsnews
@drchoueiri
@ema_news
@serviciopublive
@buscandomedicin

Top Mentioned in G1:
@clinicalphase
@renal_bio
@harerutoiiyone
@lungcancer_bio
@melanoma_bio
@drugapprovalbio
@biologicalb

Top Mentioned in G2:
@andybiotech
@ideapharma
@matthewherper
@semodough
@johncendpts
@bradloncar
@vantageanalysis
@byamybrown
@odibro
@jacobplieth

Top Mentioned in G3:
@oncomedven
@serviciopublive
@buscandomedicin
@quimioterapiao
@sebuscasedona
@medicinasve
@sosmedicina
@publserv
@esedesalud
@ayudasosvzla

Top Mentioned in G4:
@fundyaraposible
@oncomedven
@gabs_perezl

Top Mentioned in G5:
@greghuntmp
@johnny70250027
@meghanmccain
@russellhoward
@paniniamerica
@nfl
@m_a_f_f
@itscammyb
@dbongino
@tsharzzi

Top Mentioned in G6:
@bmsnews
@merck
@moffittnews
@aiims1742
@us_fda
@fwpharma
@aarpadvocates
@semodough
@emilykatehayes
@abbvie

Top Mentioned in G7:
@drchoueiri
@ema_news
@amerseburger
@kca_journal
@kidneycancer
@d
@bmsnews
@kccure
@dgurologie
@michaelstaehler

Top Mentioned in G8:
@mehrdad_dehqani

Top Mentioned in G9:
@barisyarkadas
@pelinunker
@dw_turkce
@nserdarturhal

Top Mentioned in G10:
@stephenvliu
@cadth_acmts
@sclc_lungcancer
@lcsmchat
@bmsnews
@tomlynchcso
@orourke_b
@cadth
@iaslc
@alfdoc2

Top Tweeters
Top Tweeters in Entire Graph:
@elnacionalweb
@alerttrade
@follementbijoux
@allstocknews
@milrecetas
@politicalhedge
@razzletazzlemag
@marketcurrents
@financialbuzz
@toneunga3

Top Tweeters in G1:
@follementbijoux
@politicalhedge
@razzletazzlemag
@marketcurrents
@financialbuzz
@realtorjairo
@stocknewswires
@1_newsnet
@newswelldone
@hedgebz

Top Tweeters in G2:
@allstocknews
@paynej247
@carolforden
@apwriter
@mogulazam
@911noplaner
@johnnosta
@scientwest
@portefeuillefun
@matthewherper

Top Tweeters in G3:
@gthaisaulestia
@arquitecty
@anselmina07
@guaracuchafb
@cotufa55
@lynetahs
@solechesoluma
@serviciopublive
@bendeci00244128
@joa0770

Top Tweeters in G4:
@movporvzla
@vlzafree
@sororita
@marlenesanoja
@argenisrbarreto
@mar_umi
@arelis_bravo
@margadsr
@anonmundial
@ruloscortos

Top Tweeters in G5:
@actionnewsjax
@nfl
@eliseerosenb827
@robertharding
@jeremyscrivens
@shea_babee
@hoarsewisperer
@bobcesca_go
@tbone7219
@yonifreedhoff

Top Tweeters in G6:
@yaabalfazl
@omi_082
@yahoofinance
@houstonchron
@spicedrum
@magnoliag2012
@jhardingal
@pharmaphorum
@jus2ibony
@mededbot

Top Tweeters in G7:
@bobacheck
@kidneycancer
@gottsled
@ema_news
@elementolab
@sdaryanani
@drchoueiri
@ablate_cancer
@eladsharonmd
@mariajribal

Top Tweeters in G8:
@newseijiro
@saeidzizo
@mohem_ni
@d_activ
@yenafaarrr
@30beeloo
@________mey
@queen_prsephone
@abolfazl_m
@zhezare

Top Tweeters in G9:
@sayginm
@ofkelikedi
@vicdnmrhmt
@pekgzgltekin
@arifkizilyalin
@umit_k
@syargc
@planetinmidle
@haticezrn
@dw_turkce

Top Tweeters in G10:
@cadth_acmts
@xemadeyaka14
@jfreemandaily
@lcsmchat
@glopesmd
@blueapple500816
@n8pennell
@govcanhealth
@oncoxo
@alfdoc2


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.